Format

Send to

Choose Destination
Immunotherapy. 2013 Sep;5(9):975-87. doi: 10.2217/imt.13.91.

CD4 T-cell immunotherapy for chronic viral infections and cancer.

Author information

1
Emory Vaccine Center, Department of Microbiology & Immunology, Emory University School of Medicine, 1510 Clifton Road, Room G211, Atlanta, GA 30322, USA.

Abstract

During chronic infections and cancer, T cells progressively lose function and become exhausted. However, effective T-cell responses are necessary to ultimately control viral infections and tumors. Hence, strategies that either restore endogenous immune responses or provide functional T cells by adoptive immunotherapy need to be explored. CD8 T cells play a prominent role in viral infections, as well as cancer, but CD4 T cells are necessary to support CD8 T-cell function. In addition, CD4 T cells exert direct effector functions, induce optimal B-cell responses and orchestrate innate immunity. Therefore, we propose that adoptive transfer strategies should exploit CD4 T cells alone or in combination with CD8 T cells, for the treatment of chronic infections and cancer. Furthermore, since adoptively transferred cells are subject to exhaustion, combining adoptive transfer therapy with immunotherapies that inhibit T-cell exhaustion should maximize the longevity and success rate of responses.

PMID:
23998732
PMCID:
PMC3864579
DOI:
10.2217/imt.13.91
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center